Oxatomide

CAS: 60607-34-3

Ref. 3D-FO26615

Produktinformation

• Name: Oxatomide
• Synonyme: 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-oneR-35443Celtect, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone, 1-[3-(4-Benzhydrylpiperazin-1-ium-1-yl)propyl]benzimidazol-2-olate, 1-[3-[4-(Diphenylmethyl)piperazin-1-ium-1-yl]propyl]-1H-benzimidazol-2-olate, 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-1,3-dihydro-2H-benzimidazol-2-one, 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-, 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-, Brn 4724760, Celtect, Cobiona, Dasten, Kw-4354, McN-JR 35443, NSC 309710, Oxatimide, Oxatomida, Oxatomida [INN-Spanish], Oxatomide [USAN:INN:BAN:JAN], Oxatomidum, Oxatomidum [INN-Latin], Oxetal, R 35443, Tinset, Unii-J31Il9Z2Ee

Beschreibung

Oxatomide is a histamine 1 (H1) antagonist that is used to treat allergic symptoms and chronic cough. It has been shown to be effective in an experimental model of chronic pulmonary airway inflammation. Oxatomide may also have anti-inflammatory effects, but these have not been well studied. Oxatomide has also been shown to have clinical relevance for the treatment of some autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 426.55 g/mol
• Formel: C₂₇H₃₀N₄O
• Reinheit: Min. 95 Area-%
• Farbe/Form: Powder
• InChl: InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)
• InChI Key: InChIKey=BAINIUMDFURPJM-UHFFFAOYSA-N
• SMILES: O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1